The pattern of amyloid accumulation in the brains of adults with Down syndrome

被引：111

作者：

Annus, Tiina ^{[1
]}

Wilson, Liam R. ^{[1
]}

Hong, Young T. ^{[2
]}

Acosta-Cabronero, Julio ^{[3
]}

Fryer, Tim D. ^{[2
]}

Cardenas-Blanco, Arturo ^{[3
]}

Smith, Robert ^{[2
]}

Boros, Istvan ^{[2
]}

Coles, Jonathan P. ^{[4
]}

Aigbirhio, Franklin I. ^{[2
]}

Menon, David K. ^{[4
]}

Zaman, Shahid H. ^{[1
,5
]}

Nestor, Peter J. ^{[3
]}

Holland, Anthony J. ^{[1
,5
]}

机构：

[1] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England

[2] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge Biomed Campus, Cambridge, England

[3] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany

[4] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge Biomed Campus, Cambridge CB2 2QQ, England

[5] Cambridgeshire & Peterborough NHS Fdn Trust, Fulbourn Hosp, Cambridge, England

来源：

ALZHEIMERS & DEMENTIA | 2016年 / 12卷 / 05期

基金：

英国医学研究理事会;

关键词：

Alzheimer's disease; Down syndrome; Amyloid; PIB; PET; Dementia; Striatum; Preclinical; POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH-COMPOUND-B; ALZHEIMERS-DISEASE; CORPUS STRIATUM; BETA PROTEIN; DEMENTIA; DEPOSITION; AGE; ASSOCIATION; PLAQUES;

D O I：

10.1016/j.jalz.2015.07.490

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: Adults with Down syndrome (DS) invariably develop Alzheimer's disease (AD) neuropathology. Understanding amyloid deposition in DS can yield crucial information about disease pathogenesis. Methods: Forty-nine adults with DS aged 25-65 underwent positron emission tomography with Pittsburgh compound-B (PIB). Regional PIB binding was assessed with respect to age, clinical, and cognitive status. Results: Abnormal PIB binding became evident from 39 years, first in striatum followed by rostral prefrontal-cingulo-parietal regions, then caudal frontal, rostral temporal, primary sensorimotor and occipital, and finally parahippocampal cortex, thalamus, and amygdala. PM binding was related to age, diagnostic status, and cognitive function. Discussion: PIB binding in DS, first appearing in striatum, began around age 40 and was strongly associated with dementia and cognitive decline. The absence of a substantial time lag between amyloid accumulation and cognitive decline contrasts to sporadic/familial AD and suggests this population's suitability for an amyloid primary prevention trial. (C) 2015 The Authors. Published by Elsevier Inc. on behalf of Alzheimer's Association.

引用

页码：538 / 545

页数：8

共 43 条

[21] Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees [J].

Klunk, William E. ;

Price, Julie C. ;

Mathis, Chester A. ;

Tsopelas, Nicholas D. ;

Lopresti, Brian J. ;

Ziolko, Scott K. ;

Bi, Wenzhu ;

Hoge, Jessica A. ;

Cohen, Ann D. ;

Ikonomovic, Milos D. ;

Saxton, Judith A. ;

Snitz, Beth E. ;

Pollen, Daniel A. ;

Moonis, Majaz ;

Lippa, Carol F. ;

Swearer, Joan M. ;

Johnson, Keith A. ;

Rentz, Dorene M. ;

Fischman, Alan J. ;

Aizenstein, Howard J. ;

DeKosky, Steven T. .

JOURNAL OF NEUROSCIENCE, 2007, 27 (23) :6174-6184

[22] PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease [J].

Koivunen, J. ;

Verkkoniemi, A. ;

Aalto, S. ;

Paetau, A. ;

Ahonen, J. -P. ;

Viitanen, M. ;

Nagren, K. ;

Rokka, J. ;

Haaparanta, M. ;

Kalimo, H. ;

Rinne, J. O. .

BRAIN, 2008, 131 :1845-1853

[23] Using Positron Emission Tomography and Carbon 11-Labeled Pittsburgh Compound B to Image Brain Fibrillar β-Amyloid in Adults With Down Syndrome Safety, Acceptability, and Feasibility [J].

Landt, Jennifer ;

D'Abrera, J. Carlos ;

Holland, Anthony J. ;

Aigbirhio, Franklin I. ;

Fryer, Tim D. ;

Canales, Roberto ;

Hong, Young T. ;

Menon, David K. ;

Baron, Jean-Claude ;

Zaman, Shahid H. .

ARCHIVES OF NEUROLOGY, 2011, 68 (07) :890-896

[24] Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation [J].

Lemere, CA ;

Blusztajn, JK ;

Yamaguchi, H ;

Wisniewski, T ;

Saido, TC ;

Selkoe, DJ .

NEUROBIOLOGY OF DISEASE, 1996, 3 (01) :16-32

[25] PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis [J].

Lockhart, A. ;

Lamb, J. R. ;

Osredkar, T. ;

Sue, L. I. ;

Joyce, J. N. ;

Ye, L. ;

Libri, V. ;

Leppert, D. ;

Beach, T. G. .

BRAIN, 2007, 130 :2607-2615

[26] THE PATHOLOGICAL ASSOCIATION BETWEEN DOWN SYNDROME AND ALZHEIMER-DISEASE [J].

MANN, DMA .

MECHANISMS OF AGEING AND DEVELOPMENT, 1988, 43 (02) :99-136

[27] Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid beta protein (A beta) only in the form of A beta(42(43)) [J].

Mann, DMA ;

Iwatsubo, T .

NEURODEGENERATION, 1996, 5 (02) :115-120

[28] CALCIFICATION OF THE BASAL GANGLIA IN DOWNS-SYNDROME AND ALZHEIMERS-DISEASE [J].

MANN, DMA .

ACTA NEUROPATHOLOGICA, 1988, 76 (06) :595-598

[29] ALZHEIMERS PRESENILE-DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWNS-SYNDROME IN MIDDLE-AGE FORM AN AGE-RELATED CONTINUUM OF PATHOLOGICAL-CHANGES [J].

MANN, DMA ;

YATES, PO ;

MARCYNIUK, B .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1984, 10 (03) :185-207

[30] [11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease [J].

Mintun, M. A. ;

LaRossa, G. N. ;

Sheline, Y. I. ;

Dence, C. S. ;

Lee, S. Y. ;

Mach, R. H. ;

Klunk, W. E. ;

Mathis, C. A. ;

DeKosky, S. T. ;

Morris, J. C. .

NEUROLOGY, 2006, 67 (03) :446-452

← 1 2 3 4 5 →